Core Scientific (CORZ) is in focus after recent news around its pivot toward high performance computing and data center infrastructure, as investors weigh this shift against the stock’s recent volatility and existing Bitcoin mining exposure.

Core Scientific’s recent pivot toward high performance computing comes after a mixed stretch in the market, with the share price down 14.9% over 30 days but up 25.6% over 90 days and a 46.9% year to date share price return. The 1 year total shareholder return of 87.8% points to strong momentum that investors are now reassessing against the higher execution and capital risks tied to new data center projects.

If Core Scientific’s move into infrastructure has your attention, it could be a good moment to widen your search and check out 52 AI infrastructure stocks

Core Scientific’s pivot toward high performance computing adds a new growth story on top of a stock that has already delivered a strong 1 year return. The key question is whether the current valuation still leaves enough potential upside to justify the additional risk.

Most Popular Narrative: 26.7% Undervalued

Compared with the most followed fair value estimate of $32.05, Core Scientific’s last close at $23.49 reflects a sizable gap that the narrative model is trying to explain.

Core Scientific secured a major HPC contract with CoreWeave, with a total revenue potential of $8.7 billion over a 12-year term, significantly boosting future revenue compared to their current levels. The company is expanding HPC infrastructure capacity by reallocating resources from Bitcoin mining, adding new sites, and extending existing ones, expecting to drive future revenue growth as data center needs rise.

Curious what justifies that higher fair value for Core Scientific? The narrative focuses on rapid revenue expansion, sharp margin improvement and a future earnings profile that looks very different from today.

Result: Fair Value of $32.05 (UNDERVALUED)

However, Core Scientific’s reliance on CoreWeave for a large portion of projected AI hosting revenue, together with recent net losses and impairment charges, could still challenge this upbeat scenario.

Another View on Core Scientific’s Valuation

While the fair value narrative for Core Scientific sits at $32.05, simple pricing checks paint a very different picture. The stock trades on a P/S of 21x, compared with 3.5x for the US Software industry and a 4.5x peer average, while the fair ratio sits at 7.2x. This suggests that a lot of expectations may already be reflected in the price.

This gap raises a practical question for investors: is the current share price giving you a margin of safety, or asking you to pay up for a story that still needs to be proved?

Next Steps

With Core Scientific’s mixed signals around growth potential and valuation, it makes sense to move quickly, review the data in detail, and weigh both the upside and downside using the 1 key reward and 2 important warning signs.

Looking for more investment ideas beyond Core Scientific?

If Core Scientific has sharpened your interest in high growth themes, do not stop here. Use the wider market to cross check ideas and pressure test your portfolio.

• Spot potential overachievers early by scanning the screener containing 19 high quality undiscovered gems before they get crowded with attention.
• Prioritise resilience and sleep better at night by filtering opportunities through the 78 resilient stocks with low risk scores that screens for steadier profiles.
• Strengthen your core holdings by focusing on companies in the solid balance sheet and fundamentals stocks screener (47 results) that emphasise robust finances and fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.